Antiimmunoglobulins of rheumatoid factor (RF) type in prediction of melanoma patients

It was found out the titer of antiimmunoglobulins of the rheumatoid factor (RF) type in the sera of melanoma patients can be used in prediction of the development of the patients' status. High titers of antiimmunoglobulins of the RF type, determined by the latex-fixation test (LFT), indicate an...

Full description

Saved in:
Bibliographic Details
Published inNeoplasma Vol. 33; no. 6; pp. 737 - 741
Main Authors Lochman, I, Tvrdík, J, Lochmanová, A, Machálek, J, Vrtná, L, Kyselá, T, Beska, F, Repisták, J, Konrád, B, Cesaný, P
Format Journal Article
LanguageEnglish
Published Slovakia 1986
Subjects
Antibody Formation
Autoantibodies - analysis
Humans
Immunoglobulins - immunology
Melanoma - immunology
Prognosis
Rheumatoid Factor - immunology
Online AccessGet full text

Cover

More Information
Summary:It was found out the titer of antiimmunoglobulins of the rheumatoid factor (RF) type in the sera of melanoma patients can be used in prediction of the development of the patients' status. High titers of antiimmunoglobulins of the RF type, determined by the latex-fixation test (LFT), indicate an unfavorable prognosis in patients with clinical manifestation of uncontrollable recurrence appearing from 1.5 to 2 years after occurrence of the LFT titer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0028-2685